| Cat.No. | Name | Information |
|---|---|---|
| M50431 | Phospho-Glycogen Synthase Peptide-2(substrate) | Phospho-Glycogen Synthase Peptide-2 (substrate) is peptide substrate for glycogen synthase kinase-3 (GSK-3) and can be used for affinity purification of protein-serine kinases. |
| M50430 | Thioether-cyclized helix B peptide, CHBP | Thioether-cyclized helix B peptide, CHBP can improve metabolic stability and renoprotective effect through inducing autophagy via inhibition of mTORC1 and activation of mTORC2. |
| M50429 | Suc-AEPF-AMC | Suc-AEPF-AMC is a peptide substrate of Pin1 and Par14 peptidyl prolyl isomerase. |
| M50428 | ND1-YL2 | ND1-YL2 is a PROTAC that selectively degrades SRC-1 via the N-degron pathway. |
| M50427 | Abl Cytosolic Substrate | Abl Cytosolic Substrate is a substrate for Abelson tyrosine kinase (Abl ). |
| M50425 | Woodtide | Woodtide is a substrate for the DYRK (DYRK) family of kinases whose sequence is based on that around the DYRK phosphorylation site in FKHR. |
| M50424 | [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) | [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates. |
| M50423 | GIP (1-30) amide, porcine | GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42). |
| M50421 | CMX-2043 | CMX-2043 is a novel analogue of α-Lipoic Acid. |
| M50420 | DA-JC4 | DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways. |
| M50419 | Acetyl Gastric Inhibitory Peptide (human) | Acetyl Gastric Inhibitory Peptide (human) is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. |
| M50418 | Gastric Inhibitory Polypeptide (1-30), porcine | Gastric Inhibitory Polypeptide (1-30), porcine lacks the C-terminal 12 amino acid residues of natural gastric inhibitory polypeptide (GIP), exhibits biologic activity by potentiating the release of insulin and somatostatin. |
| M50417 | [Tyr0] Gastric Inhibitory Peptide (23-42), human | [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. |
| M50416 | GIP (1-30) amide, human | GIP (1-30) amide,human is a glucose-dependent insulinotropic polypeptide (GIP) fragment. |
| M50415 | human GIP(3-30), amide | human GIP(3-30), amide is a high affinity antagonist of the human GIP receptor in vitro. |
| M50413 | Trichomide A | Trichomide A is a potent activator of SHP2. |
| M50412 | CD31 | CD31 (PECAM-1) is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). |
| M50411 | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH is a high-affinity pentapeptide to bind to the src SH2 domain (IC50≈1 µM). |
| M50410 | p60c-src substrate II | p60c-src substrate II is an efficient pentapeptide substrate for the tyrosine kinase pp60c-src. |
| M50409 | Caffeic acid-pYEEIE | Caffeic acid-pYEEIE, a non-phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
